Mahkam Zanganeh, CEO: Summit Therapeutics SMMT Buy · Filed 23/12/13

Trade details

Type: Insider buy
Amount: $10,350
Shares · price: 5,000 sh · $2.07 a share
Held after: 494,814 sh
Stock: Summit Therapeutics SMMT
Person: Mahkam ZanganehCEO
Trade date: 23/12/12
Filed: 23/12/13
Days to filing: 1 days

2 insiders bought this week

Insiders buying this week: 2 insiders
Holding change: +1.0%

Summit Therapeutics trades, last 26 weeks

What else happened in Summit Therapeutics around then

Filed or reported within 30 days of the trade day · 23/11/12~24/01/11

Mahkam Zanganeh's recent trades

Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$50M
3,810,000 sh
$50M
Filed 06/12
Traded 06/12
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$1.5M
100,000 sh
$1.5M
Filed 06/04
Traded 06/04
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$500K
26,680 sh
$500K
Filed 25/10/23
Traded 25/10/21
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$5.9M
333,394 sh
$5.9M
Filed 25/09/11
Traded 25/09/10
Mahkam ZanganehCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$90.4K
5,000 sh
$90.4K
Filed 25/09/11
Traded 25/09/11

Mahkam Zanganeh, CEO — bought $10.3K of Summit Therapeutics SMMT · 5,000 sh @ $2.07 | Whalegun